Publication

Article

BioPharm International

BioPharm International-03-02-2011
Volume2011 Supplement
Issue 2

BioPharm International, March 2011 Supplement (PDF)

Global Outsourcing

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
Sidebar_t-711284-1408621012852.jpg
Supply-Chain Transformation: Strategic Necessity for the Life Sciences
Carrier_Figure-2-711282-1408621018203.jpg
Key Considerations When Outsourcing Cell-Culture Medium Development
Abraham_Figure1-711283-1408621016004.jpg
Successful Technology Transfer, Process Validation, and Partnership with a CMO
BP0311suppBolonFigures_2-711281-1408621021555.jpg
Sponsor-CMO Conflict Management for Clinical-Phase Biologics
BioPharm International, March 2011 Supplement (PDF)

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Pendulum used for readings and hypnotism swinging with motion blur | Image Credit: © fergregory - stock.adobe.com
August 11th 2025

Prasad Returns to Head FDA’s CBER

Christopher Cole
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 11th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
airborn virus floating aroud in droplets on blue sky background | Image Credit: ©the_lightwriter -stock.adobe.com
August 11th 2025

New Technologies for Viral Clearance

Cynthia A. Challener
Mastering Antibody-Drug Conjugates
August 11th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 11th 2025

European TICC group, Normec, Gains Foothold in US Market with Three Strategic Acquisitions

Feliza Mirasol
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 11th 2025

FDA Accepts Breyanzi sBLA from Bristol Myers Squibb and Grants It Priority Review for MZL

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.